Biopharmaceutics and Drug Disposition
Journal Title
- Biopharmaceutics and Drug Disposition
ISSN
- E 1099-081X | P 0142-2782
Publisher
- John Wiley & Sons Inc.
Listed on(Coverage)
| JCR | 1997-2023 |
|---|---|
| SJR | 1999-2020;2022-2023 |
| CiteScore | 2011-2023 |
| SCI | 2010-2019 |
| SCIE | 2010-2024 |
| CC | 2016-2024 |
| SCOPUS | 2017-2024 |
| MEDLINE | 2016-2024 |
| EMBASE | 2016-2024 |
Active
- Active
based on the information
- SCOPUS:2024-10
Country
- USA
Aime & Scopes
- & Drug Disposition publishes original review articles, short communications, and reports in biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those that have a direct relation to the drug discovery/development and the therapeutic use of drugs. These includes: · animal and human pharmacological studies that focus on therapeutic response. pharmacodynamics, and toxicity related to plasma and tissue concentrations of drugs and their metabolites /// in vitro and in vivo drug absorption, distribution, metabolism, transport, and excretion studies that facilitate investigations related to the use of drugs in man /// studies on membrane transport and enzymes, including their regulation and the impact of pharmacogenomics on drug absorption and disposition, /// simulation and modeling in drug discovery and development /// theoretical treatises /// includes themed issues and reviews The journal excludes manuscripts on /// bioavailability studies reporting only on simple PK parameters such as Cmax, tmax and t1/2 without mechanistic interpretation /// analytical methods Reports must contain current citation of the literature and convey new information. Biopharmaceutics & Drug Disposition is one of the top accessed and cited journals in the field, as a result of the high quality papers published in the journal, and is marketed by Wiley across the world.